NASDAQ·Pharmaceutical Preparations

SYRESpyre Therapeutics, Inc.

Spyre Therapeutics, Inc. (SYRE) has a auditor change flag.

Last filing: filing·May 5, 2026EDGAR ↗

SYRE Risk Flags

Consolidated view of every risk_flag row SYREhas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	10-K · Feb 19, 2026	PCAOB-tagged auditor in 10-K filed 2026-02-19 (accession 0001636282-26-000020) was 'KPMG LLP' (PCAOB Firm ID: 185). Prior 10-K filed 2025-02-27 (accession 0001636282-25-000020) was 'PricewaterhouseCoopers LLP' (PCAOB Firm ID: 238).	view ↗

Related on SYRE

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.